Press Resease

Animal Healthcare Market - Global Industry Analysis

Animal Healthcare Market by Drug Type (Anti-Infective Agents, Anti-Inflammatory Agents, Parasiticides, Vaccines, Hormones and Substitutes, and Others), by Animal Type (Companion Animals and Farm Animals), by Route of Administration (Oral, Parenteral, Topical, and Others), and by Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Published Date: 27-Jun-2018 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-473 Status : Published

Global animal healthcare market expected to reach around USD 41.78 billion by end of 2024, growing at a CAGR of around 4.53% between 2018 and 2024. The animal healthcare market is segmented on the basis of drug type into anti-inflammatory agents, anti-infective agents, parasiticides, vaccines, hormones and substitutes, and others.

Description

The report covers forecast and analysis for the animal healthcare market on a global and regional level. The study provides the historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the animal healthcare market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the animal healthcare market on a global level.

In order to give the users of this report a comprehensive view on the animal healthcare market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein drug type, animal type, route of administration, distribution channel, and regional segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new distribution channel launch, agreements, partnerships, collaborations & joint ventures, research & development, distribution channel, and regional expansion of major participants involved in the market on the global and regional basis. 

Global Animal Healthcare Market

The study provides a decisive view on the animal healthcare market by segmenting the market based on drug type, animal type, route of administration, distribution channel, and regions. All the segments have been analyzed based on present and the future trends and the market is estimated from 2018 to 2024. Based on drug type, the market is segmented into anti-inflammatory agents, anti-infective agents, parasiticides, vaccines, hormones and substitutes, and others. Based on the animal type, the market is segmented into companion animals and farm animals. Based on the route of administration, the market is segmented into topical, oral, parenteral, and others. Distribution channel segment is divided into veterinary clinics, veterinary hospitals, pharmacies and drug stores, and online pharmacies. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further categorization into major countries.

Some of the key players in animal healthcare market include Boehringer Ingelheim GmbH, Virbac SA, Zoetis, Inc., Bayer AG, Intas Pharmaceuticals, Ltd., Elanco (Eli Lilly and Company), Vetoquinol SA, Zydus Animal Health, Dechra Pharmaceuticals, Ceva Sante Animale, Merck Animal Health, and others.

This report segments the global animal healthcare market as follows:

Global Animal Healthcare Market: Drug Type Segment Analysis

  • Anti-Infective Agents
    • Antibiotics and Antimicrobial
    • Antifungal
    • Antiviral
  • Anti-Inflammatory Agents
  • Parasiticides
    • Ecto-Parasiticides
    • Endo-Parasiticides
    • Endectocides
  • Vaccines
  • Hormones & Substitutes
  • Others

Global Animal Healthcare Market: Animal Type Segment Analysis

  • Companion Animals
  • Farm Animals

Global Animal Healthcare Market: Route of Administration Segment Analysis

  • Oral
  • Parenteral
  • Topical
  • Others

Global Animal Healthcare Market: Distribution Channel Segment Analysis

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Online Pharmacies

Global Animal Healthcare Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global animal healthcare market, 2017 - 2024 (USD Billion)
    • 2.2. Global animal healthcare market: snapshot
  •  
  • Chapter 3. Animal Healthcare Market- Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global animal healthcare market drivers: impact analysis
      • 3.2.2. Widespread implementation of animal vaccination programs
    • 3.3. Market Restraints
      • 3.3.1. Global animal healthcare market restraints: impact analysis
      • 3.3.2. Over usage of antibiotics is negatively impacting antibiotic sales in animal healthcare market
    • 3.4. Opportunities
      • 3.4.1. Rise in demand for pet insurance
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by drug type segment
      • 3.6.2. Market attractiveness analysis, by animal type segment
      • 3.6.3. Market attractiveness analysis, by route of administration segment
      • 3.6.4. Market attractiveness analysis, by distribution channel segment
      • 3.6.5. Market attractiveness analysis, by regional segment
  •  
  • Chapter 4. Global Animal Healthcare Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global animal healthcare market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
    • 4.3. Price trend analysis
  •  
  • Chapter 5. Global Animal Healthcare Market- Drug Type Segment Analysis
    • 5.1. Global animal healthcare market: drug type overview
      • 5.1.1. Global animal healthcare market revenue share, by drug type, 2017 and 2024
    • 5.2. Anti-Infective Agents
      • 5.2.1. Global animal healthcare market for anti-infective agents, 2017 - 2024 (USD Billion)
    • 5.3. Anti-Inflammatory Agents
      • 5.3.1. Global animal healthcare market for anti-inflammatory agents, 2017 - 2024 (USD Billion)
    • 5.4. Parasiticides
      • 5.4.1. Global animal healthcare market for parasiticides, 2017 - 2024 (USD Billion)
    • 5.5. Vaccines
      • 5.5.1. Global animal healthcare market for vaccines, 2017 - 2024 (USD Billion)
    • 5.6. Hormones & Substitutes
      • 5.6.1. Global animal healthcare market for hormones & substitutes, 2017 - 2024 (USD Billion)
    • 5.7. Others
      • 5.7.1. Global animal healthcare market for others, 2017 - 2024 (USD Billion)
  •  
  • Chapter 6. Global Animal Healthcare Market- Animal Type Segment Analysis
    • 6.1. Global animal healthcare market: animal type overview
      • 6.1.1. Global animal healthcare market revenue share, by animal type, 2017 and 2024
    • 6.2. Companion Animals
      • 6.2.1. Global animal healthcare market for companion animals, 2017 - 2024 (USD Billion)
    • 6.3. Farm Animals
      • 6.3.1. Global animal healthcare market for farm animals, 2017 - 2024 (USD Billion)
  •  
  • Chapter 7. Global Animal Healthcare Market- Route of Administration Segment Analysis
    • 7.1. Global animal healthcare market: route of administration overview
      • 7.1.1. Global animal healthcare market revenue share, by route of administration, 2017 and 2024
    • 7.2. Oral
      • 7.2.1. Global animal healthcare market for oral, 2017 - 2024 (USD Billion)
    • 7.3. Parenteral
      • 7.3.1. Global animal healthcare market for parenteral, 2017 - 2024 (USD Billion)
    • 7.4. Topical
      • 7.4.1. Global animal healthcare market for topical, 2017 - 2024 (USD Billion)
    • 7.5. Others
      • 7.5.1. Global animal healthcare market for others, 2017 - 2024 (USD Billion)
  •  
  • Chapter 8. Global Animal Healthcare Market- Distribution Channel Segment Analysis
    • 8.1. Global animal healthcare market: distribution channel overview
      • 8.1.1. Global animal healthcare market revenue share, by distribution channel, 2017 and 2024
    • 8.2. Veterinary Hospitals
      • 8.2.1. Global animal healthcare market for veterinary hospitals, 2017 - 2024 (USD Billion)
    • 8.3. Veterinary Clinics
      • 8.3.1. Global animal healthcare market for veterinary clinics, 2017 - 2024 (USD Billion)
    • 8.4. Pharmacies & Drug Stores
      • 8.4.1. Global animal healthcare market for pharmacies & drug stores, 2017 - 2024 (USD Billion)
    • 8.5. Online Sales
      • 8.5.1. Global animal healthcare market for online sales, 2017 - 2024 (USD Billion)
  •  
  • Chapter 9. Global Animal Healthcare Market- Regional Segment Analysis
    • 9.1. Global animal healthcare market: regional overview
      • 9.1.1. Global animal healthcare market revenue share, by region, 2017 and 2024
    • 9.2. North America
      • 9.2.1. North America animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
      • 9.2.2. North America animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
      • 9.2.3. North America animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
      • 9.2.4. North America animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
      • 9.2.5. U.S.
        • 9.2.5.1. U.S. animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
        • 9.2.5.2. U.S. animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
        • 9.2.5.3. U.S. animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
        • 9.2.5.4. U.S. animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
      • 9.2.6. Canada
        • 9.2.6.1. Canada animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
        • 9.2.6.2. Canada animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
        • 9.2.6.3. Canada animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
        • 9.2.6.4. Canada animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
    • 9.3. Europe
      • 9.3.1. Europe animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
      • 9.3.2. Europe animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
      • 9.3.3. Europe animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
      • 9.3.4. Europe animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
      • 9.3.5. U.K.
        • 9.3.5.1. U.K. animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
        • 9.3.5.2. U.K. animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
        • 9.3.5.3. U.K. animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
        • 9.3.5.4. U.K. animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
      • 9.3.6. Germany
        • 9.3.6.1. Germany animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
        • 9.3.6.2. Germany animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
        • 9.3.6.3. Germany animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
        • 9.3.6.4. Germany animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
      • 9.3.7. France
        • 9.3.7.1. France animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
        • 9.3.7.2. France animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
        • 9.3.7.3. France animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
        • 9.3.7.4. France animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
      • 9.3.8. Rest of Europe
        • 9.3.8.1. Rest of Europe animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
        • 9.3.8.2. Rest of Europe animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
        • 9.3.8.3. Rest of Europe animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
        • 9.3.8.4. Rest of Europe animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
      • 9.4.2. Asia Pacific animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
      • 9.4.3. Asia Pacific animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
      • 9.4.4. Asia Pacific animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
      • 9.4.5. China
        • 9.4.5.1. China animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
        • 9.4.5.2. China animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
        • 9.4.5.3. China animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
        • 9.4.5.4. China animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
      • 9.4.6. Japan
        • 9.4.6.1. Japan animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
        • 9.4.6.2. Japan animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
        • 9.4.6.3. Japan animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
        • 9.4.6.4. Japan animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
      • 9.4.7. India
        • 9.4.7.1. India animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
        • 9.4.7.2. India animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
        • 9.4.7.3. India animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
        • 9.4.7.4. India animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
      • 9.4.8. Rest of Asia Pacific
        • 9.4.8.1. Rest of Asia Pacific animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
        • 9.4.8.2. Rest of Asia Pacific animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
        • 9.4.8.3. Rest of Asia Pacific animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
        • 9.4.8.4. Rest of Asia Pacific animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
    • 9.5. Latin America
      • 9.5.1. Latin America animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
      • 9.5.2. Latin America animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
      • 9.5.3. Latin America animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
      • 9.5.4. Latin America animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
      • 9.5.5. Brazil
        • 9.5.5.1. Brazil animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
        • 9.5.5.2. Brazil animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
        • 9.5.5.3. Brazil animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
        • 9.5.5.4. Brazil animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
      • 9.5.6. Rest of Latin America
        • 9.5.6.1. Rest of Latin America animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
        • 9.5.6.2. Rest of Latin America animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
        • 9.5.6.3. Rest of Latin America animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
        • 9.5.6.4. Rest of Latin America animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
    • 9.6. Middle East and Africa
      • 9.6.1. Middle East and Africa animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
      • 9.6.2. Middle East and Africa animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
      • 9.6.3. Middle East and Africa animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
      • 9.6.4. Middle East and Africa animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
      • 9.6.5. Saudi Arabia
        • 9.6.5.1. Saudi Arabia animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
        • 9.6.5.2. Saudi Arabia animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
        • 9.6.5.3. Saudi Arabia animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
        • 9.6.5.4. Saudi Arabia animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
      • 9.6.6. UAE
        • 9.6.6.1. UAE animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
        • 9.6.6.2. UAE animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
        • 9.6.6.3. UAE animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
        • 9.6.6.4. UAE animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
      • 9.6.7. South Africa
        • 9.6.7.1. South Africa animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
        • 9.6.7.2. South Africa animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
        • 9.6.7.3. South Africa animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
        • 9.6.7.4. South Africa animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
      • 9.6.8. Rest of Middle East and Africa
        • 9.6.8.1. Rest of Middle East and Africa animal healthcare market revenue, by drug type, 2017 - 2024 (USD Billion)
        • 9.6.8.2. Rest of Middle East and Africa animal healthcare market revenue, by animal type, 2017 - 2024 (USD Billion)
        • 9.6.8.3. Rest of Middle East and Africa animal healthcare market revenue, by route of administration, 2017 - 2024 (USD Billion)
        • 9.6.8.4. Rest of Middle East and Africa animal healthcare market revenue, by distribution channel, 2017 - 2024 (USD Billion)
  •  
  • Chapter 10. Company Profile
    • 10.1. Boehringer Ingelheim GmbH
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Therapy portfolio
      • 10.1.4. Business strategy
      • 10.1.5. Recent developments
    • 10.2. Virbac SA
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Therapy portfolio
      • 10.2.4. Business strategy
      • 10.2.5. Recent developments
    • 10.3. Zoetis, Inc.
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Therapy portfolio
      • 10.3.4. Business strategy
      • 10.3.5. Recent developments
    • 10.4. Bayer AG
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Therapy portfolio
      • 10.4.4. Business strategy
      • 10.4.5. Recent developments
    • 10.5. Intas Pharmaceuticals, Ltd.
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Therapy portfolio
      • 10.5.4. Business strategy
      • 10.5.5. Recent developments
    • 10.6. Elanco (Eli Lilly and Company)
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Therapy portfolio
      • 10.6.4. Business strategy
      • 10.6.5. Recent developments
    • 10.7. Vetoquinol SA
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Therapy portfolio
      • 10.7.4. Business strategy
      • 10.7.5. Recent developments
    • 10.8. Zydus Animal Health
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Therapy portfolio
      • 10.8.4. Business strategy
      • 10.8.5. Recent developments
    • 10.9. Dechra Pharmaceuticals
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Therapy portfolio
      • 10.9.4. Business strategy
      • 10.9.5. Recent developments
    • 10.10. Ceva Sante Animale
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Therapy portfolio
      • 10.10.4. Business strategy
      • 10.10.5. Recent developments
    • 10.11. Merck Animal Health
      • 10.11.1. Overview
      • 10.11.2. Financials
      • 10.11.3. Therapy portfolio
      • 10.11.4. Business strategy
      • 10.11.5. Recent developments

List of Figures 

1. Market research process
2. Market methodology
3. Global animal healthcare market revenue, 2017 – 2024 (USD Billion) 
4. Porter’s five forces analysis
5. Animal healthcare market attractiveness analysis, by drug type segment
6. Animal healthcare market attractiveness analysis, by animal type segment
7. Animal healthcare market attractiveness analysis, by route of administration segment
8. Animal healthcare market attractiveness analysis, by distribution channel segment
9. Animal healthcare market: market attractiveness analysis, by regional segment
10. Company market share analysis, 2017 
11. Global animal healthcare market revenue share by drug type, 2017 and 2024
12. Global animal healthcare market for anti-infective agents, 2017 – 2024 (USD Billion)
13. Global animal healthcare market for anti-inflammatory agents, 2017 – 2024 (USD Billion)
14. Global animal healthcare market for parasiticides, 2017 – 2024 (USD Billion)
15. Global animal healthcare market for vaccines, 2017 – 2024 (USD Billion)
16. Global animal healthcare market for hormones & substitutes, 2017 – 2024 (USD Billion)
17. Global animal healthcare market for others, 2017 – 2024 (USD Billion)
18. Global animal healthcare market revenue share by animal type, 2017 and 2024
19. Global animal healthcare market for companion animals, 2017 – 2024 (USD Billion)
20. Global animal healthcare market for farm animals, 2017 – 2024 (USD Billion)
21. Global animal healthcare market revenue share by route of administration, 2017 and 2024
22. Global animal healthcare market for oral, 2017 – 2024 (USD Billion)
23. Global animal healthcare market for parenteral, 2017 – 2024 (USD Billion)
24. Global animal healthcare market for topical, 2017 – 2024 (USD Billion)
25. Global animal healthcare market for others, 2017 – 2024 (USD Billion)
26. Global animal healthcare market revenue share by distribution channel, 2017 and 2024
27. Global animal healthcare market for veterinary hospitals, 2017 – 2024 (USD Billion)
28. Global animal healthcare market for veterinary clinics, 2017 – 2024 (USD Billion)
29. Global animal healthcare market for pharmacies & drug stores, 2017 – 2024 (USD Billion)
30. Global animal healthcare market for others, 2017 – 2024 (USD Billion)
31. Global animal healthcare market revenue share by regions, 2017 and 2024
32. North America animal healthcare market, 2017 – 2024, (USD Billion)
33. Europe animal healthcare market, 2017 – 2024, (USD Billion)
34. Asia Pacific animal healthcare market, 2017 – 2024, (USD Billion)
35. Latin America animal healthcare market, 2017 – 2024, (USD Billion)
36. The Middle East and Africa animal healthcare market, 2017 – 2024, (USD Billion)


List of Tables

1. Animal healthcare market: market snapshot                                                                
2. Drivers of global animal healthcare market: impact analysis 
3. Restraints of global animal healthcare market: impact analysis  
4. North America animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
5. North America animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
6. North America animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
7. North America animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion)
8. U.S. animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
9. U.S. animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
10. U.S. animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
11. U.S. animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion)
12. Canada animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
13. Canada animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
14. Canada animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
15. Canada animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion
16. Europe animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
17. Europe animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
18. Europe animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
19. Europe animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion
20. U.K. animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
21. U.K. animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
22. U.K. animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
23. U.K. animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion
24. Germany animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
25. Germany animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
26. Germany animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
27. Germany animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion
28. France animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
29. France animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
30. France animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
31. France animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion
32. Rest of Europe animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion) 
33. Rest of Europe animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
34. Rest of Europe animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
35. Rest of Europe animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion
36. Asia Pacific animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
37. Asia Pacific animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
38. Asia Pacific animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
39. Asia Pacific animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion
40. China animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
41. China animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
42. China animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
43. China animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion
44. Japan animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
45. Japan animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
46. Japan animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
47. Japan animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion
48. India animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
49. India animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
50. India animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
51. India animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion
52. Rest of Asia Pacific animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
53. Rest of Asia Pacific animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
54. Rest of Asia Pacific animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
55. Rest of Asia Pacific animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion
56. Latin America animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
57. Latin America animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
58. Latin America animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
59. Latin America animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion
60. Brazil animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
61. Brazil animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
62. Brazil animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
63. Brazil animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion
64. Rest of Latin America animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
65. Rest of Latin America animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
66. Rest of Latin America animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
67. Rest of Latin America animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion
68. Middle East and Africa animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
69. Middle East and Africa animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
70. Middle East and Africa animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
71. Middle East and Africa animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion
72. Saudi Arabia animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
73. Saudi Arabia animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
74. Saudi Arabia animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
75. Saudi Arabia animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion
76. UAE animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
77. UAE animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
78. UAE animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
79. UAE animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion
80. South Africa animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
81. South Africa animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
82. South Africa animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
83. South Africa animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion
84. Rest of Middle East and Africa animal healthcare market revenue, by drug type, 2017 – 2024 (USD Billion)
85. Rest of Middle East and Africa animal healthcare market revenue, by animal type, 2017 – 2024 (USD Billion)
86. Rest of Middle East and Africa animal healthcare market revenue, by route of administration, 2017 – 2024 (USD Billion)
87. Rest of the Middle East and Africa animal healthcare market revenue, by distribution channel, 2017 – 2024 (USD Billion

Methodology

Free Analysis

Rising prevalence of parasitic and infectious diseases has led to the innovations in managing animal healthcare. The distinction between animal health and animal production has been changed in the recent times due to the increasing prevalence of animal diseases. Modern medicine in association with technology is more focused on improving livestock and animal health production. Other driving factors such as the rising concerns related to zoonotic diseases which impact both humans and animals have a great effect on the economies of countries globally. This has led to a collective focus on improving the safety and quality of food products thus assuring efficacious animal healthcare products in order to reduce the impact on the economies worldwide.

The significant rise in animal farming has led to a rise in demand for animal health services to improve veterinary public health and food safety systems in order to safeguard human health. The adoption of animal healthcare services is highly dependent on the fiscal, political, and institutional factors of the country. Governments are taking initiatives to increase the adoption of animal health services by increasing awareness among the general population regarding animal diseases and privatization of animal healthcare services. Livestock insurance is one such scheme in Europe, which is implemented to increase the efficiency and effectiveness of animal healthcare systems. Another initiative is of the U.K. government compensating on direct losses incurred due to the outbreaks from the U.K. national budget and Europe compensation schemes.

The animal healthcare market is segmented on the basis of drug type, animal type, route of administration, and distribution channel. Based on drug type, the market is segmented into anti-inflammatory agents, anti-infective agents, parasiticides, vaccines, hormones and substitutes, and others. Based on the animal type, animal healthcare market is segmented into companion animals and farm animals. Based on the route of administration, market is segmented into topical, oral, parenteral, and others. Distribution channel segment is divided into veterinary clinics, veterinary hospitals, pharmacies and drug stores, and online pharmacies.

Global Animal Healthcare Market

North America is anticipated to lead the animal healthcare market due to increasing government initiatives. Governments throughout the countries are optimizing the veterinary healthcare by establishing persistent healthcare policies in order to control the chronic conditions and endemic diseases. Animals are more susceptible to a wide range of infectious diseases caused by parasites, viruses, bacteria, and fungi. Vaccination is the effective way to control the outbreak of such diseases in animals. Vaccination plays a major role in preventive healthcare for controlling the diseases and epidemics in both farm and companion animals. Governments are keenly involved in control and prevention of animal diseases by creating educational systems and advisory to raise awareness amongst the population. Due to this many developed economies have also introduced incentive programs and compensation schemes to improve animal healthcare.

Some of the key players in animal healthcare market include Boehringer Ingelheim GmbH, Virbac SA, Zoetis, Inc., Bayer AG, Intas Pharmaceuticals, Ltd., Elanco (Eli Lilly and Company), Vetoquinol SA, Zydus Animal Health, Dechra Pharmaceuticals, Ceva Sante Animale, Merck Animal Health, and others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +1 (844) 845-52454
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-52454
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social